H3N2 subclade K drives severe U.S. flu season; dominates ~90% of cases
H3N2 subclade K is driving an unusually severe U.S. flu season, making up roughly 90% of H3N2 infections and coinciding with CDC estimates of about 7.5 million illnesses, 81,000 hospitalizations and 3,100 deaths to date, with high or very-high activity concentrated across the Northeast, Midwest and South and record weekly case counts in places like New York. Public-health officials and the WHO call subclade K a notable evolution — it has several mutations versus the vaccine reference strains and appears to partially evade prior immunity — which likely contributed to the rapid spread even without clear evidence of greater intrinsic virulence. Experts say the current vaccine may be somewhat mismatched but still helps prevent severe disease and hospitalization, and they urge vaccination and other precautions amid lower-than-usual coverage.
📌 Key Facts
- H3N2 subclade K is driving this season’s U.S. outbreak and comprises roughly 89–92% of recent H3N2/subtyped influenza A viruses — essentially about 90% of circulating H3N2 cases.
- CDC burden estimates (most recently updated in late December) put the season so far at about 7.5 million illnesses, 81,000 hospitalizations and 3,100 deaths (including eight pediatric deaths); weekly hospital admissions have spiked by roughly 10,000 to more than 19,000 in the latest week.
- Flu activity is widespread and intensifying — concentrated particularly in the Northeast, Midwest and South — with 32 jurisdictions at high or very high influenza‑like‑illness levels; New York State logged roughly 71,000 lab‑confirmed cases in one week (week ending Dec. 20), its highest weekly total on record.
- Experts and WHO say subclade K represents a 'notable evolution' of H3N2; the currently used H3N2 vaccine reference strains (2024–25 J and 2025–26 J.2) differ from K by multiple mutations (K has seven distinct differences), indicating a likely strain mismatch for H3N2.
- Despite the mismatch, early U.K. data and other analyses show the current vaccine still reduces risk of severe disease and hospitalization (roughly estimated at ~30–40% effectiveness for preventing adult hospitalization), so vaccination is still recommended to lower severe outcomes.
- Contributing factors to the rapid spread include reduced population immunity and lower‑than‑usual vaccination coverage (U.S. adult coverage around 42%); experts caution there is no formal medical definition of a 'super flu' even as the term is used colloquially for subclade K.
- The surge is straining local health systems and disrupting communities: recent sharp rises in hospitalizations (e.g., New York’s >3,600 hospitalizations in one week), big increases among children in places like Boston, and regional impacts such as schools temporarily shifting to online learning in some areas.
- Public‑health observers criticize the federal communication and vaccination outreach this season; experts and public health officials urge continued vaccination, monitoring for symptoms, and prompt medical care for people at high risk of complications as the K‑driven wave is expected to continue for weeks into peak season.
📊 Relevant Data
In the 2023-2024 influenza season, age-adjusted cumulative hospitalization rates per 100,000 population were 127.5 for non-Hispanic Black persons, 85.9 for non-Hispanic American Indian or Alaska Native persons, 60.2 for non-Hispanic White persons, 55.6 for Hispanic persons, and 31.6 for non-Hispanic Asian or Pacific Islander persons.
Flu hospitalization rates are 1.8 times higher among Black adults, 1.4 times higher among American Indian or Alaska Native adults, and 1.2 times higher among Hispanic adults compared to White adults, associated with social determinants of health like access to health care and economic, social, and environmental conditions.
Systemic inequities in the United States lead to higher rates of underlying medical conditions in Black, Indigenous, and other People of Color (BIPOC) populations, which may worsen influenza outcomes.
Closing the Gap in Race-based Inequities for Seasonal Influenza Vaccination — Clinical Infectious Diseases
📰 Sources (8)
Why the flu season is so bad and how you can protect yourself
New information:
- PBS segment features an extended expert interview with Dr. Andrew Pekosz of Johns Hopkins, elaborating on why subclade K is spreading so efficiently this season.
- The interview emphasizes that the current subclade K–driven wave is expected to last for weeks to come as the U.S. enters peak flu season.
- The piece focuses on practical guidance for individuals on what to watch for and how best to protect themselves during this specific subclade K wave (e.g., seasonal timing, risk framing), adding nuance beyond aggregate CDC statistics.
Why flu cases are surging this season. And, protests erupt in Iran over the economy
New information:
- NPR reiterates CDC estimates that at least 7.5 million people have been sickened and more than 3,100 have died from flu so far this season, consistent with existing figures.
- The article emphasizes that early U.K. data indicate this season's U.S. flu vaccine, while mismatched against subclade K, still appears effective at preventing hospitalization.
- It highlights expert criticism that the federal government has not mounted a strong flu-vaccination campaign this season, suggesting a communication and policy gap rather than a scientific failure.
Flu cases are surging and rates will likely get worse, new CDC data shows
New information:
- CDC reports more than 19,000 flu hospital admissions in the latest week, up about 10,000 from the prior week, indicating a very steep week-over-week rise.
- New York State logged over 71,000 lab-confirmed flu cases in a single week, the most cases ever recorded in one week since state reporting began.
- Geographic detail that high flu activity is now concentrated particularly in the U.S. Northeast, Midwest and South, with national flu-activity maps described as “mostly red.”
- Expert assessment that H3N2 subclade K is likely benefiting from reduced population immunity, helping explain the rapid spread even without evidence it is more severe or inherently more transmissible.
- Preliminary United Kingdom data indicating this season’s flu vaccine is about 30–40% effective at preventing hospitalization in adults, described as in line with typical flu-vaccine performance despite a likely strain mismatch.
- Updated U.S. adult vaccination coverage figure of about 42% so far this season, along with criticism from former CDC official Demetre Daskalakis that CDC’s public communication around flu vaccination has not been sufficiently robust.
Flu cases spiking this holiday season, CDC data shows
New information:
- CDC now estimates at least 7.5 million flu illnesses, 81,000 hospitalizations and 3,100 deaths this season as of Dec. 20, including eight pediatric deaths.
- Flu activity has intensified with 32 jurisdictions at high or very high influenza-like illness levels, up from 17 just one week earlier.
- New York State reported about 71,000 flu cases and over 3,600 hospitalizations in the week ending Dec. 20 — its highest weekly case count since tracking began in 2004.
- Boston recorded a 114% increase in recent flu cases, with the largest spike among children, while Minnesota has seen 113 flu-related hospitalizations in 2025, more than double last year and enough to push at least one school to temporary online learning.
- Of 2,086 flu-positive specimens reported to CDC between Dec. 13 and Dec. 20, 2,029 were influenza A; among 1,627 subtyped A viruses, about 92% were H3N2, reinforcing dominance of this subtype.
- Experts quoted say H3N2 has evolved enough to partially evade prior immunity, the vaccine is expected to be mismatched for H3N2 but better matched for H1N1 and flu B, and early UK data suggest current vaccines still help prevent severe disease, especially in children.
"Super flu" surge: What to know about spiking flu cases and the surging "Super K" variant
New information:
- Reiterates CDC burden estimates of at least 7.5 million illnesses, 81,000 hospitalizations and 3,100 deaths so far this season but frames them as an 'unprecedented' rise in flu cases.
- Reports that nearly 90% of new U.S. flu cases (H3N2) are from subclade K, based on the latest CDC tracking data.
- Details that the current H3N2 vaccine reference strains are 2024–25 subclade J and updated 2025–26 subclade J.2, while the circulating subclade K has seven distinct mutations compared with those references.
- Notes that U.K. and Canadian officials saw rising hospitalizations in fall 2025 tied to this H3N2 strain and raised early warnings.
- Adds anecdotal regional context: New York’s week ending Dec. 20 set a state record for weekly positive flu cases; Connecticut doctors report case levels as the highest they have ever seen; California, and specifically LA County, are experiencing a particularly worrying season.
- Conveys expert clarification that 'super flu' is a sensational term without formal medical meaning, even as it is being used colloquially for subclade K.
Flu cases skyrocket across the U.S.
New information:
- CBS cites CDC estimates that nearly five million flu cases have occurred nationwide so far this season.
- The same CDC estimates indicate at least 1,900 people have died from flu in the U.S. this season.
- The segment notes that this year’s strain is breaking records in terms of spread/severity, reinforcing that the current season is unusually intense.
Flu by state: Where this season’s highly contagious variant is spreading the most
New information:
- CDC FluView data for the week ending Dec. 13, 2025 show that New York City, New York State, New Jersey, Rhode Island, Louisiana, and Colorado are in the 'Very High' range for outpatient respiratory-illness activity, with Massachusetts, Connecticut, Michigan, Idaho, South Carolina, New Mexico, Washington, D.C., Maryland, North Carolina, and Georgia in 'High' ranges.
- Among 216 influenza A(H3N2) viruses collected since Sept. 28, 89.8% belonged to the H3N2 subclade K, according to CDC.
- CDC estimates for the current U.S. flu season so far include at least 4.6 million illnesses, 49,000 hospitalizations, and 1,900 deaths.
- The WHO is quoted as calling H3N2 subclade K a 'notable evolution' of H3N2 viruses, raising questions among experts about how well this season’s flu vaccine matches the new variant.
- Public health expert Dr. Neil Maniar states that subclade K is contributing to an 'aggressive' flu season, notes that vaccination rates are lower than usual and that the current vaccine may not be perfectly aligned with subclade K, but emphasizes that vaccination still offers protection against severe illness.